Wilmington, NC10 Active Studies

Ankylosing Spondylitis Clinical Trials in Wilmington, NC

Find 10 actively recruiting ankylosing spondylitis clinical trials in Wilmington, NC. Connect with local research sites and explore new treatment options.

10
Active Trials
9
Sponsors
2,124
Enrolling

Recruiting Ankylosing Spondylitis Studies in Wilmington

RecruitingWilmington, NCNCT06932263

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolle...

540 participants
AstraZeneca
View Study Details
RecruitingWilmington, NCNCT05918211

Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo for the treatment of adolescent who have had the F...

436 participants
Mezzion Pharma Co. Ltd
View Study Details
RecruitingWilmington, NCNCT06290401

A Socio-ecological Approach for Improving Self-management in Adolescents With SCD

The goal of this clinical trial is to evaluate the impact of SCThrive (a behavioral self-management intervention) on patient activation, self-management behaviors, daily functioning, and emergency roo...

310 participants
Children's Hospital Medical Center, Cincinnati
View Study Details
RecruitingWilmington, NCNCT06124157

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

This pilot trial assesses the effect of the combination of blinatumomab with dasatinib or imatinib and standard chemotherapy for treating patients with Philadelphia chromosome positive (Ph+) or ABL-cl...

222 participants
National Cancer Institute (NCI)
View Study Details
RecruitingWilmington, NCNCT05660746

Precise Infliximab Exposure and Pharmacodynamic Control

Approximately 3 million people in the United States are living with inflammatory bowel disease, which includes Crohn's Disease (CD). There are limited treatment options approved for use in children an...

180 participants
Children's Hospital Medical Center, Cincinnati
View Study Details
RecruitingWilmington, NCNCT06647953

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

This phase III trial tests how well surgery plus chemotherapy compared to surgery alone works in treating patients with type I pleuropulmonary blastoma (PPB), and tests how well surgery plus standard ...

110 participants
Children's Oncology Group
View Study Details
RecruitingWilmington, NCNCT02323399

Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IV

The primary objective of this study is to evaluate the dose effect of Phenylephrine Hydrochloride Injection on the treatment of clinically relevant decreased blood pressure in the pediatric population...

100 participants
West-Ward Pharmaceutical
View Study Details
RecruitingWilmington, NCNCT06842355

A Study of TYRA-300 in Children With Achondroplasia: BEACH301

The purpose of this study is to evaluate the safety, tolerability, and identify potentially effective dose(s) of TYRA-300 in children with achondroplasia with open growth plates....

92 participants
Tyra Biosciences, Inc
View Study Details
RecruitingWilmington, NCNCT05003986

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

To evaluate the safety, efficacy and tolerability of sparsentan oral suspension and tablets, and assess changes in proteinuria after once-daily dosing over 108 weeks....

67 participants
Travere Therapeutics, Inc.
View Study Details
RecruitingWilmington, NCNCT04315324

Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)

This phase I/II trial studies the safety, side effects and best dose of OBI-3424 and how well it works in treating patients with T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma th...

67 participants
SWOG Cancer Research Network
View Study Details

About Ankylosing Spondylitis Clinical Trials in Wilmington

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 10 ankylosing spondylitis clinical trials recruiting participants in Wilmington, NC. These studies are seeking a combined 2,124 participants. Research is being sponsored by AstraZeneca, Mezzion Pharma Co. Ltd, Children's Hospital Medical Center, Cincinnati and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Wilmington — FAQ

Are there ankylosing spondylitis clinical trials in Wilmington?

Yes, there are 10 ankylosing spondylitis clinical trials currently recruiting in Wilmington, NC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Wilmington?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Wilmington research site will contact you about next steps.

Are clinical trials in Wilmington free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Wilmington studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 10 active trials in Wilmington are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov